Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

302 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid.
Sathyasaikumar KV, Notarangelo FM, Kelly DL, Rowland LM, Hare SM, Chen S, Mo C, Buchanan RW, Schwarcz R. Sathyasaikumar KV, et al. Among authors: buchanan rw. Pharmaceuticals (Basel). 2022 Aug 15;15(8):1003. doi: 10.3390/ph15081003. Pharmaceuticals (Basel). 2022. PMID: 36015151 Free PMC article.
The effects of galantamine on psychopathology in chronic stable schizophrenia.
Conley RR, Boggs DL, Kelly DL, McMahon RP, Dickinson D, Feldman S, Ball MP, Buchanan RW. Conley RR, et al. Among authors: buchanan rw. Clin Neuropharmacol. 2009 Mar-Apr;32(2):69-74. doi: 10.1097/WNF.0B013E31816F2795. Clin Neuropharmacol. 2009. PMID: 18978489 Free PMC article. Clinical Trial.
White matter alterations in deficit schizophrenia.
Rowland LM, Spieker EA, Francis A, Barker PB, Carpenter WT, Buchanan RW. Rowland LM, et al. Among authors: buchanan rw. Neuropsychopharmacology. 2009 May;34(6):1514-22. doi: 10.1038/npp.2008.207. Epub 2008 Dec 3. Neuropsychopharmacology. 2009. PMID: 19052539 Free PMC article.
Effects of the cannabinoid-1 receptor antagonist rimonabant on psychiatric symptoms in overweight people with schizophrenia: a randomized, double-blind, pilot study.
Kelly DL, Gorelick DA, Conley RR, Boggs DL, Linthicum J, Liu F, Feldman S, Ball MP, Wehring HJ, McMahon RP, Huestis MA, Heishman SJ, Warren KR, Buchanan RW. Kelly DL, et al. Among authors: buchanan rw. J Clin Psychopharmacol. 2011 Feb;31(1):86-91. doi: 10.1097/JCP.0b013e318204825b. J Clin Psychopharmacol. 2011. PMID: 21192149 Free PMC article. Clinical Trial.
302 results